CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) Institutional Ownership

CUSIP: 163572209

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2023

Type / Class
Equity / COM NEW
Symbol
CEMI
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Investment Quick Answers

What is CUSIP 163572209?
CUSIP 163572209 identifies CEMI - CHEMBIO DIAGNOSTICS INC - COM NEW in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Institutional Holders of CHEMBIO DIAGNOSTICS INC - COM NEW (CEMI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2023 Q3 0 $0 -$170 0
2023 Q2 375 $170 -$1,267,815 $0.45 1
2023 Q1 2,871,703 $1,271,751 +$32,857 $0.44 25
2022 Q4 2,886,437 $634,289 -$122,289 $0.22 31
2022 Q3 3,175,066 $1,147,068 +$176,088 $0.36 27
2022 Q2 2,410,213 $1,568,262 -$160,232 $0.65 30
2022 Q1 2,835,866 $2,321,046 -$1,046,574 $0.82 31
2021 Q4 4,018,776 $4,579,647 -$731,982 $1.14 37
2021 Q3 3,970,146 $9,930,670 -$2,765,199 $2.50 42
2021 Q2 4,845,815 $14,394,051 -$6,765,984 $2.97 56
2021 Q1 6,965,342 $24,452,323 -$6,034,981 $3.51 69
2020 Q4 8,369,765 $39,882,542 +$8,312,417 $4.75 76
2020 Q3 6,284,805 $30,534,224 -$2,071,565 $4.86 59
2020 Q2 7,300,513 $23,729,372 -$2,295,643 $3.25 73
2020 Q1 6,995,171 $35,809,682 -$313,832 $5.12 41
2019 Q4 7,241,805 $33,020,000 -$1,076,847 $4.56 38
2019 Q3 7,382,435 $45,163,000 +$5,687,554 $6.12 44
2019 Q2 7,260,093 $44,197,000 +$3,414,740 $6.09 38
2019 Q1 6,718,206 $37,286,000 -$3,975,854 $5.55 37
2018 Q4 7,506,584 $42,486,000 +$3,109,298 $5.66 41
2018 Q3 6,839,379 $71,813,000 +$4,908,012 $10.50 32
2018 Q2 6,370,697 $70,714,000 +$5,177,914 $11.10 31
2018 Q1 5,904,570 $47,236,000 +$11,860,661 $8.00 26
2017 Q4 4,422,003 $36,260,000 +$1,984,832 $8.20 21
2017 Q3 4,173,806 $25,878,000 +$2,469,381 $6.20 19
2017 Q2 3,797,369 $22,975,000 +$537,441 $6.05 24
2017 Q1 3,730,374 $19,770,000 -$1,456,310 $5.30 24
2016 Q4 4,038,739 $27,461,000 +$7,090,137 $6.80 25
2016 Q3 3,050,176 $22,517,000 +$8,962,729 $7.39 26
2016 Q2 1,833,298 $15,013,000 +$2,322,776 $8.19 25
2016 Q1 1,565,589 $9,378,000 -$301,480 $5.99 21
2015 Q4 1,615,507 $8,611,000 +$63,127 $5.33 19
2015 Q3 1,618,057 $6,532,000 -$1,050,284 $4.01 21
2015 Q2 1,843,790 $9,053,275 -$244,675 $4.91 22
2015 Q1 1,894,308 $7,542,040 -$810,637 $4.02 19
2014 Q4 2,098,383 $8,191,000 +$838,584 $3.92 23
2014 Q3 1,741,417 $6,479,000 +$195,209 $3.72 17
2014 Q2 1,689,422 $5,795,000 +$291,831 $3.43 17
2014 Q1 1,604,634 $5,511,000 +$650,392 $3.43 18